Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 82.80
-0.40 (-0.48%)
Oct 2, 2026, 4:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 507.43 million as of October 2, 2026.
Market Cap
507.43M
Enterprise Value
402.69M
Revenue
24.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.80
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 507.43M, an increase of 172.22%. That is a compound annual growth rate of 195.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 507.43M | 130.77% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.86B |
| Thor Medical ASA | 1.88B |
| Nykode Therapeutics AS | 1.13B |
| ArcticZymes Technologies ASA | 1.03B |
| Lytix Biopharma ASA | 635.19M |
| Zelluna ASA | 600.04M |
| SoftOx Solutions AS | 338.23M |
| Arctic Bioscience AS | 75.48M |